Compared to mouse monoclonal antibodies, rabbit monoclonal antibodies are higher-affinity and easier to humanize. Learn more: https://lnkd.in/gn66MDKj #Animalstudy #Immunotherapy #AntibodyEngineering #CancerTherapy
ProMab Biotechnologies, Inc.
生物技术
Richmond，CA 1,575 位关注者
Your Trusted Partner for Cutting-Edge Antibody, mRNA-LNP Solutions, and Immunotherapy Breakthroughs.
关于我们
ProMab Biotechnologies, Inc is a revolutionizing biotechnology company that integrates cutting edge technologies to serve the global biomedical research community. We specialize in recombinant proteins, antibodies and engineered cell lines on which we are known to have built a superior reputation for quality and reliability. Our commitment to Excellence is exemplified by our newest service where we provide mRNA-LNP product and services that allows a swift and effective response to emerging infectious diseases. Join us in shaping the future of biotechnology and scientific progress. For more inquiries, visit our webiste: https://www.promab.com/. Email: info@promab.com
- 网站
-
http://www.promab.com
ProMab Biotechnologies, Inc.的外部链接
- 所属行业
- 生物技术
- 规模
- 201-500 人
- 总部
- Richmond，CA
- 类型
- 私人持股
- 创立
- 2001
- 领域
- Monoclonal antibody production、Stem cell, and cancer stem cell specific monoclonals and research reagents、Recombinant protein expression in bacteria, insect, and mammalian systems、Polyclonal antibody production、CAR T-cell Products and Services、CAR NK-cell Products and Services、Antibody Engineering、Immunotherapy、Hybridoma Sequencing、Gene Synthesis、Contract Research Organization、Bispecific antibodies、scFv recombinant antibodies、Human phage display library、Human antibodies、T-cell activation beads、T-cell expansion media、peptide synthesis和Bispecific antibodies
地点
-
主要
获取路线
2600 Hilltop Dr
Building B,
US，CA，Richmond，94806
ProMab Biotechnologies, Inc.员工
动态
-
💡 Discover the Latest in Cancer Immunotherapy Research! Check out this recent publication exploring innovative approaches to cancer vaccines and immunotherapy. Learn how cutting-edge advancements are driving new possibilities in targeted treatments. 📄 Read the full article here: https://lnkd.in/g5mPNPyh #CancerResearch #Immunotherapy #CancerVaccines #BiotechInnovation
-
-
🎥 Unlock the potential of mRNA-derived CAR-T cells for cancer immunotherapy! Check out this video showcasing a non-viral method for generating transient CAR-T cells using mRNA—offering a safer, faster, and more cost-effective approach to cancer treatment. 🧬💥 📹 Watch the full video here: https://lnkd.in/gzZynPzD We provide CAR-T cell development service using either mRNA-lipid nanoparticle (LNP) or electroporation! 👇 #CancerImmunotherapy #mRNACART #CARTCells #BiotechInnovation
-
-
Unlock the Power of mRNA-LNP Technology! Join us for ProMab’s Webinar on March 27, 2025, featuring Dr. Liang Hu, Ph.D., as he shares the latest advancements in mRNA in vitro transcription and LNP technology for protein, antibody, and CAR expression. Date: March 27, 2025 Time: 11 AM PDT | 2 PM EDT Register here: https://lnkd.in/gP8NJY8Y https://lnkd.in/gh957G3c #ProMab #mRNALNP #GeneTherapy #CancerResearch #Immunotherapy #BiotechInnovation
-
-
🔬 Boost Your Research with mRNA-LNP Technology 💡 Join ProMab’s Webinar – March 27, 2025 🔗 Register now: https://lnkd.in/gP8NJY8Y https://lnkd.in/gh957G3c #ProMab #mRNALNP #BiotechInnovation #CARTEngineering #ProteinEngineering
此处无法显示此内容
在领英 APP 中访问此内容等
-
🔬 Precision in Cell Line Engineering 🧬 Looking to analyze protein function with greater accuracy? ProMab’s Engineered Stable Cell Line Services offer CRISPR-based gene knockout to create custom cell lines that truly reflect biological function. ✅ Compare functional vs. knockout cell lines ✅ Reliable gene deletion & expression validation ✅ Custom solutions tailored to your research Whether you're deleting a gene to study its impact or developing stable cell lines for therapeutic applications, we’ve got you covered! Learn more: https://lnkd.in/g4A4xKgj #CellLineEngineering #CRISPR #GeneKnockout #StableCellLines #ProMab
-
Looking for a safer and more potent way to engineer CAR-T cells? Gamma delta T cells are not MHC-restricted, making them ideal for allogeneic use with a lower risk of GvHD. ProMab’s custom γδ CAR-T cells show rapid expansion and high expression of tumor-targeting receptors. We’re ready when you are! Explore our custom gamma delta CAR-T development: https://lnkd.in/gGRPQFyp #CARTCells #GammaDeltaTCells #CancerTherapy #Immunotherapy #ProMab
-
-
💭 What’s next for mRNA and LNP technology? Join Dr. Liang Hu as he unpacks the latest in mRNA in vitro transcription and lipid nanoparticles for protein, antibody, and CAR expression. 📅 March 27, 2025 | ⏰ 11 AM PDT / 2 PM EDT 🔗 Register now: https://lnkd.in/gP8NJY8Y https://lnkd.in/gh957G3c #mRNA #LNP #Biotech #GeneExpression #AntibodyDevelopment #ProMab
-
-
Attention!! Ready-to-Use mRNA-LNPs for Immunotherapy Research! ProMab Biotechnologies now offers mRNA-LNP formulations for IL-7, IL-21, and 4-1BBL—designed to accelerate your immunotherapy studies. Our high-efficiency LNPs provide a streamlined solution for your research, helping you move forward with confidence. Explore our latest mRNA-LNP offerings today! Learn more: https://lnkd.in/emjKhWn6 #Immunotherapy #mRNA #LNP #CancerResearch #Biotech #ProMab
-
-
Revolutionize Your Research with AI! ProMab Biotechnologies is using AI-driven acceleration to enhance antibody and CAR-T development. Our cutting-edge approach optimizes binding affinity and functionality, helping researchers achieve groundbreaking results. What breakthrough will you discover next? See how AI can boost your research: https://lnkd.in/g-cMF7kB #AIinBiotech #AntibodyDevelopment #CARTCells #ProMabBiotech #BiotechInnovation
-